NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2091220388

Registered date:27/09/2018

Basic Information

Recruitment status PENDING
Health condition(s) or Problem(s) studied
Date of first enrollment01/10/2018
Target sample size20
Countries of recruitmentJapan,United Kingdom,France,Italy,Austria,South Korea,Denmark,Belgium
Study typeInterventional
Intervention(s)Intervention type:DRUG Name of intervention: Dose form / Japanese Medical Device Nomenclature:TABLET Route of administration / Site of application:ORAL Dose per administration:100~300 mg Dosing frequency / Frequency of use:QD Planned duration of intervention: Intended dose regimen: detailes of teratment arms: Comparative intervention name: Dose form / Japanese Medical Device Nomenclature:INJECTION,INJECTION,INJECTION Route of administration / Site of application:INTRAVENOUS DRIP,INTRAVENOUS DRIP,INTRAVENOUS DRIP Dose per administration:14,1000~1200,120 mg/m^2,mg/m^2,mg/m^2 Dosing frequency / Frequency of use:OTHER, SPECIFY,OTHER, SPECIFY,OTHER, SPECIFY Planned duration of intervention: Intended dose regimen:

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteria
Exclude criteria

Related Information

Contact

Public contact
Name
Address
Telephone
E-mail mbjpcti@celgene.com
Affiliation
Scientific contact
Name
Address
Telephone
E-mail mbjpcti@celgene.com
Affiliation